US Patent Issued to PMCR on March 31 for "HLA tumor antigen peptides of class I and II for treating mammary/breast carcinomas" (German Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,142, issued on March 31, was assigned to PMCR GMBH (Karlsruhe, Germany).

"HLA tumor antigen peptides of class I and II for treating mammary/breast carcinomas" was invented by Wolfgang Schonharting (Bad Wiessee, Germany) and Sybille Urban (Bad Wiessee, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for use in the treatment or prophylaxis of mammary/breast carcinomas, in particular locally recurring or metastasizing mammary carcinomas in a patient or group of patients, who has or is suspected of having a breast carcinoma, comprising at least 4 to 8 HLA-A tumor antigen peptides corr...